A randomized trial in China finds improved outcome with intra-arterial tenecteplase following thrombectomy, but further confirmatory trials are needed.
A systematic review and meta-analysis shows that standard-dose dual therapy lowers systolic blood pressure more than monotherapy at twice the standard dose.